Expression of programmed death-1 (PD-1) and its ligand PD-L1 is upregulated in endometriosis and promoted by 17beta-estradiol
article
OA: closed
CC0
⤵ 36 in-corpus citations
AI-generated summary
Programmed death-1 (PD-1) and its ligand PD-L1 are upregulated in endometriosis, with 17beta-estradiol promoting PD-L1 expression in endometrial cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The programmed death-1 (PD-1)/PD-L1 pathway plays important roles in immune responses and peripheral tolerance. Under pathological conditions, this pathway can suppress protective T cell responses and induce immune system disorders. Endometriosis (EM) is an estrogen-dependent, immune-associated disease. The expression of PD-1 and PD-L1 has been studied in a variety of cancers and autoimmune diseases. Few studies, however, have attempted to explore their expression and the possibility that they are regulated by estrogen in EM. Eutopic and ectopic endometria and blood samples were collected from 15 women with EM and 15 women without EM. PD-1/PD-L1 expression in endometrial tissues was detected using immunohistochemistry and western blot analysis. Their expression in blood was detected using flow cytometry. In addition, their expression was evaluated in endometrial cells after estrogen and cytokine treatment. We observed PD-1/PD-L1 expression in both eutopic and ectopic endometria, with elevated expression in EM. Their expression was also higher in CD4+/CD8+ T cells in blood from EM patients. In addition, treatment with 17β-estradiol upregulated PD-L1 expression in eutopic epithelial cells in EM. These data suggest that the PD-1/PD-L1 pathway may be involved in EM immune dysfunction and be regulated by estrogen.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- Characterization of endometriosis-associated immune cell infiltrates (EMaICI) via openalex
- Endometriotic stromal cells lose the ability to regulate cell-survival signaling in endometrial epithelial cells in vitro via openalex
- Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance via openalex
- Expression of inflammatory cytokines in serum and peritoneal fluid from patients with different stages of endometriosis via openalex
- Immunological Aspects of Endometriosis: An Update via openalex
- Lymphocytes in Endometriosis via openalex
- Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. via openalex
- Pathophysiology and Immune Dysfunction in Endometriosis via openalex
- PRL-3 Is Involved in Estrogen- and IL-6–Induced Migration of Endometrial Stromal Cells From Ectopic Endometrium via openalex
- The Role of the Lymphatic System in Endometriosis: A Comprehensive Review of the Literature1 via openalex
- W2055260228 via openalex
- W2075819066 via openalex
- W2092921437 via openalex
- W2108855090 via openalex
- W2018968534 via openalex
- W2155464214 via openalex
- W2160834915 via openalex
- W2013013791 via openalex
- W2300386653 via openalex
- W2339303388 via openalex
- W2402976159 via openalex
- W1984545852 via openalex
- W2497866798 via openalex
- W2551403261 via openalex
- W2024150595 via openalex
- W1893566975 via openalex
- W2040164466 via openalex
- W2048810850 via openalex
Cited by (36)
- Endometrial expression of T-cell immunoreceptor with Ig and ITIM domains and cluster of differentiation 155: A case-control study of a novel immunomodulatory axis in endometriosis 2026
- WISP2/CCN5 revealed as a potential diagnostic biomarker for endometriosis based on machine learning and single-cell transcriptomic analysis 2025
- Reframing Endometriosis: Interplay of NETs, Macrophages, and Lymphocytes at the Crossroads of Disease Progression, Infertility, and Malignant Transformation 2025
- Integration of Single Cell and Bulk RNA-Sequencing Reveals Key Genes and Immune Cell Infiltration to Construct a Predictive Model and Identify Drug Targets in Endometriosis 2025
- Emerging Mechanisms of NK Cell Dysfunction in Endometriosis: The Role of Autophagy, Metabolism, Cytokines, Exosomes, and Trogocytosis 2025
- PD-1 Expression in Endometriosis 2025
- Anthropometric characteristics and features of the systemic inflammatory response in patients with endometriosis 2024
- Does Programmed Cell Death 1 Ligand (Pd-L1) Expression Predict Recurrence in Women With Endometrioma? 2024
- Endometriosis: A Comprehensive and Concise Review of Potential Biomarkers and Treatment Therapies 2024
- Immune сheckpoints in the context of external genital endometriosis 2024
- Immune Checkpoints in Endometriosis—A New Insight in the Pathogenesis 2024
- An integrated multi-tissue approach for endometriosis candidate biomarkers: a systematic review 2024
- The mysterious association between adiponectin and endometriosis 2024
- Therapeutic effects of melatonin on endometriosis, targeting molecular pathways: Current knowledge and future perspective 2023
- Exosomes: potential diagnostic markers and drug carriers for adenomyosis 2023
- The role of CD8+ T cells in endometriosis: a systematic review 2023
- Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives 2023
- Expression of Gal-9 on Dendritic Cells and Soluble Forms of TIM-3/Gal-9 in Patients Suffering from Endometriosis 2023
- A higher number of exhausted local PD1+, but not TIM3+, NK cells in advanced endometriosis 2023
- Immune and endocrine regulation in endometriosis: what we know 2023
- The Promises of Natural Killer Cell Therapy in Endometriosis 2022
- Estrogen Regulates the Expression and Function of lncRNA-H19 in Ectopic Endometrium 2022
- Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis 2022
- Macrophage-associated immune checkpoint CD47 blocking ameliorates endometriosis 2022
- Endometriosis through an immunological lens: a pathophysiology based in immune dysregulation 2022
- Serum Level of Ligand Programmed Death-1 in Endometriosis 2022
- The double engines and single checkpoint theory of endometriosis 2022
- Epigenetic regulation and T-cell responses in endometriosis – something other than autoimmunity 2022
- Natural Killer Cell Receptors and Endometriosis: A Systematic Review 2022
- The Double Engines and Single Checkpoint Theory of Endometriosis 2022
- Endometriosis stromal cells induce bone marrow mesenchymal stem cell differentiation and PD-1 expression through paracrine signaling 2021
- Low-dose aspirin can downregulate progesterone resistance and increase the expression of LIF in endometriosis during the implantation window 2021
- Soluble immune checkpoints CTLA‐4, HLA‐G, PD‐1, and PD‐L1 are associated with endometriosis‐related infertility 2020
- NK Cells as Potential Targets for Immunotherapy in Endometriosis 2019
- The Origin and Pathogenesis of Endometriosis 2019
- Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology 2019
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:19:31.300640+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK